2012
ROKIT, Inc. established.
2016 - 2017
· Launched world's first 4D Bioprinter Dr. INVIVO 4D2
· ROKIT EU established collaboration with Fraunhofer IBMT.
2019. 06.
· Secured US$30 million in investment.
2019. 07.
· ROKIT Genomics Inc. established. (KOREA)
· ROKIT America, Inc. established. (USA)
2019. 08.
· Conducted Skin & DFU regeneration clinical trial - Hycare Hospital in
India
2019. 11.
· Joint research on cartilage - Massachusetts General Hospital in
USA.
· Awarded tech challenge award in AAPS.
2019. 12.
· Selected as top 50 healthcare company in IFAH.
2020. 04.
· Conducted Skin & DFU regeneration clinical trial - Korea University
Guro Hospital.
2020. 07.
Attracted investments from DRADS Capital.
2020. 10.
· Conducted Cartilage regeneration clinical trial - Assiut Medical
University.
2020. 12.
· Conducted DFU regeneration clinical trial in the US PI: Dr. David
Armstrong.
2021.
· Skin Regeneration Platform global partnership – Mexico, Turkey, Korea, India.
2021. 03.
· First KIT export to Cigalah UAE.
2021. 04.
· Conducted DFU & Burn clinical trial - Ankara City Hospital in Turkey.
2021. 05.
· Conducted DFU clinical trial - UKM Hospital in Malaysia.
2021. 10.
· Presented US DFU clinical data awarded 3rd place in DFCON.
2022.
· Export skin regeneration kit to India, Brazil, Paraguay.
2022. 02.
· Scaffold Kit US FDA registration.
2022. 04.
· Conducted skin cancer clinical trial – Korea University Guro Hospital.